Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

9880	Companies
198767	Keywords
129753	Articles
105686	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 1 year 10 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 1 year 10 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 1 year 10 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 1 year 10 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 1 year 10 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 1 year 10 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 1 year 10 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 1 year 10 months ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 1 year 10 months ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 1 year 10 months ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 02/17/2026 at 22:30, 20 minutes ago

Matador Technologies Announces Grant of Stock Options
Published on 02/17/2026 at 22:25, 25 minutes ago

CORRECTION FROM SOURCE: IBC Advanced Alloys Announces Execution of Definitive Funding Agreement with The Lind Partners for an Initial Funding of US$1,250,000
Published on 02/17/2026 at 22:25, 25 minutes ago

Zentek Provides Strategic and Regulatory Update
Published on 02/17/2026 at 21:56, 54 minutes ago

IBC Advanced Alloys Announces Execution of Definitive Funding Agreement with The Lind Partners for an Initial Funding of US$1,250,000
Published on 02/17/2026 at 20:00, 2 hours 50 minutes ago

Taranis Identifies Borr Zone Using EM, Prepares for Drilling on East Side of Lamprophyre Dyke

View all ACCESSWIRE

EQS Group

Published on 02/17/2026 at 22:15, 35 minutes ago

Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed
Published on 02/17/2026 at 22:05, 45 minutes ago

Immunic Announces Closing of Oversubscribed Private Placement Financing
Published on 02/17/2026 at 19:26, 3 hours 24 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/17/2026 at 18:30, 4 hours 20 minutes ago

Avolta secures major dining contract at Toronto Pearson
Published on 02/17/2026 at 18:15, 4 hours 35 minutes ago

Belvilla launches his first hotel in Belgium

Les Echos

Published on 02/17/2026 at 22:00, 50 minutes ago

Solocal - 2025 Annual Results
Published on 02/17/2026 at 22:00, 50 minutes ago

Solocal - Résultats annuels 2025
Published on 02/17/2026 at 18:46, 4 hours 4 minutes ago

Covivio Hotels annual results for 2025: A solid growth trajectory
Published on 02/17/2026 at 18:46, 4 hours 4 minutes ago

Covivio Hotels - Résultats annuels 2025 : Une trajectoire de croissance solide
Published on 02/16/2026 at 17:45, 1 day 5 hours ago

Cegedim : Déclaration d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE